Cardiac Surgery
Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms
12 Jan, 2021 | 01:38h | UTCAssociation of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm – JAMA Surgery (free for a limited period)
Commentaries: Fluoroquinolones and Aortic Disease—Is It Time to Broaden the Warning? – JAMA (free for a limited period) AND Study links fluoroquinolones to higher risk of aneurysm – CIDRAP AND Analysis Links Fluoroquinolones to Increased Aortic Aneurysm Risk – Physician’s Weekly
2020 ACC/AHA Guideline for the management of patients with valvular heart disease
18 Dec, 2020 | 09:45h | UTCNews release: Updated guideline for heart valve disease spotlights less invasive treatments
Key Perspectives: Part 1
Key Perspectives: Part 2
Key Perspectives: Part 3
Commentary on Twitter
New ACC/@American_Heart Guideline for the Management of patients with #cvVHD includes expanded treatment options; recommends less invasive interventions, when possible; and stresses the importance of #SharedDecisionMaking. Read it in #JACC: https://t.co/g9RE9buXNC pic.twitter.com/jnwt8d5QC7
— JACC Journals (@JACCJournals) December 17, 2020
Review: Mechanical complications of acute myocardial infarction
11 Dec, 2020 | 09:19h | UTCMechanical Complications of Acute Myocardial Infarction: A Review – JAMA Cardiology
Videos: Acute Rupture of Left Ventricular Aneurysm AND Ventricular Septal Rupture AND Papillary Muscle Rupture
Review: Perioperative venous thromboembolism prophylaxis
3 Dec, 2020 | 08:28h | UTCPerioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
#AHA20 – Randomized trial: In patients with atrial fibrillation and a bioprosthetic mitral valve, Rivaroxaban (20 mg) was noninferior to Warfarin (INR 2-3) for death, MACE, or major bleeding at 12 months
16 Nov, 2020 | 02:01h | UTCRivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Rivaroxaban may be as effective as warfarin for bioprosthetic mitral valves, AF – American Heart Association
Commentaries: Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib – TCTMD AND Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation – RIVER – American College of Cardiology AND Rivaroxaban Noninferior to Warfarin for Atrial Fibrillation in Patients with Bioprosthetic Mitral Valves – NEJM Journal Watch
Commentary on Twitter
In a trial comparing rivaroxaban with dose-adjusted warfarin, rivaroxaban was noninferior to warfarin with respect to the mean time until the primary outcome of death, major cardiovascular events, or major bleeding at 12 months. #AHA20
— NEJM (@NEJM) November 14, 2020
Safe surgery: A cluster randomized trial showed that the implementation of control charts with feedback on indicators to surgical teams was associated with concomitant reductions in major adverse events in patients
9 Nov, 2020 | 01:23h | UTC
JACC Review: Evaluation and management of patients with stable angina. Based on large clinical trials, medical therapy rather than revascularization is the initial management strategy for most patients
6 Nov, 2020 | 09:43h | UTCEvaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review – Journal of the American College of Cardiology (free for a limited period)
Summary: Evaluation and Management of Patients With Stable Angina – American College of Cardiology
Association between industry payments to physicians and device selection in ICD implantation
4 Nov, 2020 | 09:40h | UTCAssociation Between Industry Payments to Physicians and Device Selection in ICD Implantation – JAMA (free for a limited period)
Editorial: Reconsidering Health Care Fraud and Abuse Laws (free for a limited period)
Commentary on Twitter
More evidence that payments from industry to physicians influence clinical decisions. Great paper led by @AmarMD99 in @YaleCardiology shows that patients most likely to receive ICD/CRD made by manufacturer that provided largest payments to their physician https://t.co/P1Hh2VAxur
— Joseph Ross (@jsross119) November 3, 2020
Review: Management of common postoperative complications
4 Nov, 2020 | 09:26h | UTCManagement of Common Postoperative Complications – Mayo Clinic Proceedings
The ‘Ten Commandments’ in the new ESC Adult Congenital Heart Disease Guidelines
29 Oct, 2020 | 08:59h | UTCOriginal guideline and commentaries: 2020 ESC Guidelines for the management of adult congenital heart disease
[Abstract Only] Redevelopment and validation of the SYNTAX score II to predict the benefit of PCI vs. CABG in patients with complex coronary artery disease
23 Oct, 2020 | 08:59h | UTCSee calculator: SYNTAX Score II calculator
Meta-analysis: Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery
14 Oct, 2020 | 09:16h | UTCOverall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary on Twitter
In an analysis of 23 randomized trials comparing CABG and PCI, PCI was associated with higher rates of cardiac, non-cardiac, and all-cause mortality. All-cause mortality should be used as endpoint in revascularization trials https://t.co/DBSvVkr3EK
— JAMA Internal Medicine (@JAMAInternalMed) October 12, 2020
#ESCCongress – 2020 ESC Guidelines for the management of adult congenital heart disease
31 Aug, 2020 | 01:13h | UTCNews Release: What happens when babies with heart defects become adults? – European Society of Cardiology
Commentary on Twitter
2020 ESC Guidelines for management of adult congenital heart diseasehttps://t.co/MPHMJ2KKIc#ESCCongress #ACHD #CardioTwitter #ESCGuidelines @ErinMichos @DrMarthaGulati @ddefariayeh @AmiBhattMD @FredWuMD @anudodejamd pic.twitter.com/4LrrnAAxZ1
— Open Heart (@Open_HeartBMJ) August 29, 2020
AHA Scientific Statement: Considerations for reduction of risk of perioperative stroke in adult patients undergoing cardiac and thoracic aortic operations
27 Aug, 2020 | 09:46h | UTCNews Release: Steps outlined to reduce the risk of stroke during, after heart surgery – American Heart Association
Top Things to Know: Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations
Commentary: Teamwork Needed to Reduce Stroke and Its Consequences in Cardiac Surgery: AHA – TCTMD
Imaging assessment of mitral and aortic regurgitation: Current state of the art
24 Aug, 2020 | 00:26h | UTCImaging assessment of mitral and aortic regurgitation: current state of the art – Heart
Review: Infective endocarditis after surgical and transcatheter aortic valve replacement
19 Aug, 2020 | 09:23h | UTC
[Abstract Only] Meta-analysis: Radial artery graft vs. saphenous vein graft in long-term cardiovascular outcomes among patients undergoing coronary artery bypass grafting
29 Jul, 2020 | 09:28h | UTCCommentary: CABG: LONG-term outcomes using radial artery vs saphenous vein – MedicalResearch.com
Guideline: Diagnosing acute aortic syndrome
21 Jul, 2020 | 09:18h | UTCCommentary: New guideline can help clinicians identify hard-to-diagnose acute aortic syndrome – News Medical
[Abstract Only] Randomized trial: Dexmedetomidine does not decrease postoperative atrial arrhythmias or delirium in patients recovering from cardiac surgery
21 Jul, 2020 | 09:16h | UTC
Related Commentary on Twitter
DECADE: in 794 cardiac surgery patients, dexmedetomidine vs saline from surgical incision till 24h led to less atrial fibrillation (30% vs 34%, n.s.), but more delirium (17% vs 12%, n.s.), and more serious events (5% vs 1% ns).
Thanks to @CritCareReviews https://t.co/ZGs1ZSGMmP— Peter Nydahl (@NydahlPeter) July 20, 2020
Cardiac Surgery during the COVID‐19 Pandemic
19 May, 2020 | 04:17h | UTC
[Abstract Only] Study: No Increased Risk of Infections with Resterilized and Reused Pacemakers or Defibrillators
11 May, 2020 | 00:21h | UTCInfections Associated with Resterilized Pacemakers and Defibrillators – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Infections With Resterilized Pacemakers and Defibrillators – American College of Cardiology AND No increased risk of infection with recycled pacemakers and defibrillators – Cardiovascular Business
Meta-Analysis: Effects of Restrictive vs. Liberal Transfusion Strategies on Longer-term Outcomes After Cardiac Surgery
5 May, 2020 | 03:54h | UTCRelated: Randomized Trial: In Patients Undergoing Cardiac Surgery, A Restrictive Transfusion Approach Does Not Increase the Risk of Acute Kidney Injury (selection of studies on the subject)
Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care
13 Mar, 2020 | 08:00h | UTCCanadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care – Canadian Journal of Cardiology (free for a limited period)
Perspective – Can You Sue an Algorithm for Malpractice? It Depends
10 Mar, 2020 | 10:19h | UTCCan you sue an algorithm for malpractice? It depends – STAT (free)
Study: People Leave Hospital After Surgery Sooner if Hospitals Follow ‘Enhanced Recovery Protocols’
3 Mar, 2020 | 07:55h | UTCPeople leave hospital after surgery sooner if hospitals follow ‘enhanced recovery protocols’ – NIHR Signal (free)
Original Study: Multicomponent hospital-led interventions to reduce hospital stay for older adults following elective surgery: a systematic review – Health Services and Delivery Research (free)